We attach herewith Annual Report of the Company for the year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raaj Medisafe India Limited has submitted its Annual Report for FY 2024-25 to BSE under Regulation 34 of the SEBI LODR Regulations. The 40th Annual General Meeting is scheduled for September 25, 2025 at 3:00 PM via video conferencing. Key items at the AGM include adoption of audited financials, re-appointment of Jt. Managing Director Navin Jhawar via rotation, and appointment of M/s. GDK & Associates as new Statutory Auditors for a 5-year term in place of outgoing M/s. V.K. Ladha & Associates. The company is also seeking shareholder approval for two Material Related Party Transactions — Rs. 1,400 lakhs with Shriji Polymers (India) Limited (22.43% of turnover) and Rs. 1,600 lakhs with Shriniwas Polyfabrics and Packwell Private Limited (25.63% of turnover) — both for FY 2025-26. M/s. M. Maheshwari & Associates is being appointed as Secretarial Auditor for FY 2025-26 to 2029-30.
Shareholders should review the two large related party transactions, which together exceed Rs. 30 crore and represent nearly half of the company's consolidated turnover — these require their approval and the promoter group is connected to both counter-parties. The statutory auditor change is a routine end-of-term rotation, not a mid-year switch.